Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review

Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice

(2014) Rana Nagarkatti et al.   PLoS Neglected Tropical Diseases

Global economic burden of Chagas disease: a computational simulation model

(2013) Bruce Y Lee et al.   LANCET INFECTIOUS DISEASES

Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease

(2013) Roger A. Ashmus et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with trypanosoma cruzi antigens

(2012) Renato Sathler-Avelar et al.   BMC INFECTIOUS DISEASES

Posttherapeutic Cure Criteria in Chagas' Disease: Conventional Serology followed by Supplementary Serological, Parasitological, and Molecular Tests

(2012) G. F. Machado-de-Assis et al.   Clinical and Vaccine Immunology

Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease

(2012) Rafael J. Argüello et al.   PLoS One

Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease

(2012) Paulo Marcos Matta Guedes et al.   PLoS Neglected Tropical Diseases

Humoral Immune Response against P2β from Trypanosoma cruzi in Persons with Chronic Chagas Disease: Its Relationship with Treatment Against Parasites and Myocardial Damage

(2011) Diana L. Fabbro et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers

(2011) Ana Fernández-Villegas et al.   BMC INFECTIOUS DISEASES

Trypanosoma cruziinfection results in the reduced expression of caveolin-3 in the heart

(2011) Daniel Adesse et al.   CELL CYCLE

Benznidazole Therapy Modulates Interferon-γ and M2 Muscarinic Receptor Autoantibody Responses in Trypanosoma cruzi-Infected Children

(2011) Romina A. Cutrullis et al.   PLoS One

Hypercoagulability biomarkers in Trypanosoma cruzi-infected patients

(2011) Dolors Tassies et al.   THROMBOSIS AND HAEMOSTASIS

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease

(2011) Rodolfo Viotti et al.   PLoS Neglected Tropical Diseases

Plasma  -Type Natriuretic Peptide As a Predictor of Mortality in Community-Dwelling Older Adults With Chagas Disease: 10-Year Follow-up of the Bambui Cohort Study of Aging

(2010) M. F. Lima-Costa et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Chagas disease in Latin American migrants: a Spanish challenge

(2010) A. Pérez-Ayala et al.   CLINICAL MICROBIOLOGY AND INFECTION

Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country

(2010) L. Murcia et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification of Novel Diagnostic Serum Biomarkers for Chagas' Disease in Asymptomatic Subjects by Mass Spectrometric Profiling

(2010) M. Ndao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

(2010) Marta de Lana et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission

(2010) Sergio Sosa-Estani et al.   Revista da Sociedade Brasileira de Medicina Tropical

Chagas disease: A Latin American health problem becoming a world health problem

(2009) Gabriel A. Schmunis et al.   ACTA TROPICA

Chagas disease in Spain, the United States and other non-endemic countries

(2009) Joaquim Gascon et al.   ACTA TROPICA

Changes inTrypanosoma cruzi–Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy

(2009) Susana A. Laucella et al.   CLINICAL INFECTIOUS DISEASES

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

(2009) Rodolfo Viotti et al.   Expert Review of Anti-Infective Therapy

Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP

(2009) Yong Wang et al.   JOURNAL OF CARDIAC FAILURE

Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

(2009) Yara M Gomes et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up

(2009) CD Fernandes et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

(2008) Jose Antonio Marin-Neto et al.   AMERICAN HEART JOURNAL

Enhanced Nitrosative Stress during Trypanosoma cruzi Infection Causes Nitrotyrosine Modification of Host Proteins

(2008) Monisha Dhiman et al.   AMERICAN JOURNAL OF PATHOLOGY

Níveis séricos de NT pro-BNP: relação com função sistólica e diastólica nas miocardiopatias e pericardiopatias

(2008) Charles Mady et al.   Arquivos Brasileiros de Cardiologia

Strategy to Assess the Overall Cytokine Profile of Circulating Leukocytes and its Association with Distinct Clinical Forms of Human Chagas Disease

(2008) D. M. Vitelli-Avelar et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection

(2008) Gretchen Cooley et al.   PLoS Neglected Tropical Diseases

Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern

(2007) Renato Sathler-Avelar et al.   MICROBES AND INFECTION